| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.824 | 0.004 | 0.824 | 5 Hydroxytryptamine antagonist | 0.78 0.004 CID_153935 0.678 0.004 CID_29984837 0.641 0.005 CID_154699696 | ||
| 0.735 | 0.004 | 0.908 | 5 Hydroxytryptamine agonist | 0.908 0.003 CID_153935 0.531 0.005 CID_29984837 0.533 0.005 CID_154699696 | CID_153935 | |
| 0.733 | 0.004 | 0.733 | Dopamine antagonist | 0.443 0.006 CID_153935 0.651 0.004 CID_29984837 0.69 0.004 CID_154699696 | ||
| 0.718 | 0.002 | 0.848 | Dopamine D1 antagonist | 0.406 0.004 CID_153935 0.708 0.002 CID_29984837 0.848 0.002 CID_154699696 | CID_154699696 | |
| 0.719 | 0.003 | 0.745 | 5 Hydroxytryptamine 2C antagonist | 0.745 0.003 CID_153935 0.364 0.006 CID_29984837 0.553 0.004 CID_154699696 | CID_153935 | |
| 0.706 | 0.003 | 0.745 | Alpha 2a adrenoreceptor antagonist | 0.745 0.003 CID_153935 0.453 0.004 CID_29984837 0.693 0.003 CID_154699696 | CID_153935 | |
| 0.706 | 0.004 | 0.706 | 5 Hydroxytryptamine 2 antagonist | 0.703 0.004 CID_153935 0.688 0.004 CID_29984837 0.579 0.005 CID_154699696 | ||
| 0.705 | 0.004 | 0.716 | 5 Hydroxytryptamine 2B antagonist | 0.716 0.003 CID_153935 0.713 0.004 CID_29984837 0.585 0.004 CID_154699696 | CID_153935 | |
| 0.69 | 0.002 | 0.69 | 5 Hydroxytryptamine 1E antagonist | 0.493 0.004 CID_153935 0.357 0.009 CID_29984837 0.603 0.003 CID_154699696 | ||
| 0.687 | 0.003 | 0.706 | Alpha 2 adrenoreceptor antagonist | 0.706 0.003 CID_153935 0.377 0.005 CID_29984837 0.637 0.003 CID_154699696 | CID_153935 | |
| 0.672 | 0.004 | 0.672 | Dopamine D4 antagonist | 0.284 0.008 CID_153935 0.194 0.013 CID_29984837 0.506 0.004 CID_154699696 | ||
| 0.669 | 0.004 | 0.669 | Alpha adrenoreceptor antagonist | 0.617 0.004 CID_153935 0.642 0.004 CID_29984837 0.62 0.004 CID_154699696 | ||
| 0.654 | 0.003 | 0.654 | 5 Hydroxytryptamine 1F antagonist | 0.619 0.004 CID_153935 0.36 0.005 CID_29984837 0.56 0.004 CID_154699696 | ||
| 0.66 | 0.009 | 0.704 | 5 Hydroxytryptamine release stimulant | 0.704 0.007 CID_153935 0.374 0.051 CID_29984837 0.607 0.014 CID_154699696 | CID_153935 | |
| 0.644 | 0.004 | 0.644 | 5 Hydroxytryptamine 2A antagonist | 0.615 0.004 CID_153935 0.592 0.004 CID_29984837 0.521 0.004 CID_154699696 | ||
| 0.639 | 0.002 | 0.639 | 5 Hydroxytryptamine 3B antagonist | 0.311 0.003 CID_153935 0.086 0.006 CID_29984837 0.266 0.003 CID_154699696 | ||
| 0.64 | 0.006 | 0.64 | HERG channel blocker | 0.559 0.01 CID_153935 0.203 0.089 CID_29984837 0.373 0.033 CID_154699696 | ||
| 0.636 | 0.003 | 0.636 | Alpha 2b adrenoreceptor antagonist | 0.542 0.004 CID_153935 0.475 0.004 CID_29984837 0.595 0.003 CID_154699696 | ||
| 0.631 | 0.004 | 0.631 | Dopamine D2 antagonist | 0.399 0.007 CID_153935 0.616 0.004 CID_29984837 0.592 0.004 CID_154699696 | ||
| 0.621 | 0.004 | 0.621 | Antihistaminic | 0.338 0.008 CID_153935 0.463 0.005 CID_29984837 0.3 0.01 CID_154699696 | ||
| 0.619 | 0.004 | 0.619 | Histamine antagonist | 0.335 0.008 CID_153935 0.463 0.005 CID_29984837 0.281 0.011 CID_154699696 | ||
| 0.617 | 0.002 | 0.617 | 5 Hydroxytryptamine 3 antagonist | 0.429 0.003 CID_153935 0.304 0.004 CID_29984837 0.306 0.004 CID_154699696 | ||
| 0.608 | 0.003 | 0.608 | Alpha 2c adrenoreceptor antagonist | 0.451 0.004 CID_153935 0.41 0.004 CID_29984837 0.563 0.003 CID_154699696 | ||
| 0.608 | 0.003 | 0.615 | Histamine H1 receptor antagonist | 0.314 0.006 CID_153935 0.615 0.003 CID_29984837 0.377 0.005 CID_154699696 | CID_29984837 | |
| 0.599 | 0.003 | 0.599 | Dopamine D5 antagonist | 0.31 0.004 CID_153935 0.397 0.003 CID_29984837 0.454 0.003 CID_154699696 | ||
| 0.568 | 0.004 | 0.568 | 5 Hydroxytryptamine 1 antagonist | 0.381 0.007 CID_153935 0.213 0.015 CID_29984837 0.411 0.006 CID_154699696 | ||
| 0.571 | 0.009 | 0.571 | Potassium channel (Voltage-sensitive) blocker | 0.492 0.015 CID_153935 0.322 0.043 CID_154699696 | ||
| 0.567 | 0.005 | 0.585 | Antiadrenergic | 0.585 0.005 CID_153935 0.556 0.005 CID_29984837 0.454 0.006 CID_154699696 | CID_153935 | |
| 0.561 | 0.004 | 0.598 | Alpha 1 adrenoreceptor antagonist | 0.52 0.005 CID_153935 0.598 0.004 CID_29984837 0.501 0.005 CID_154699696 | CID_29984837 | |
| 0.559 | 0.005 | 0.559 | Anesthetic general | 0.397 0.017 CID_153935 0.252 0.05 CID_29984837 0.55 0.005 CID_154699696 | ||
| 0.557 | 0.005 | 0.573 | Adrenaline antagonist | 0.573 0.005 CID_153935 0.549 0.005 CID_29984837 0.445 0.007 CID_154699696 | CID_153935 | |
| 0.546 | 0.004 | 0.546 | 5 Hydroxytryptamine 7 antagonist | 0.4 0.005 CID_153935 0.074 0.035 CID_29984837 0.302 0.005 CID_154699696 | ||
| 0.564 | 0.025 | 0.851 | Antiobesity | 0.79 0.005 CID_153935 0.851 0.005 CID_29984837 0.428 0.056 CID_154699696 | CID_29984837 | |
| 0.53 | 0.003 | 0.53 | Dopamine D3 antagonist | 0.28 0.006 CID_153935 0.26 0.007 CID_29984837 0.437 0.004 CID_154699696 | ||
| 0.521 | 0.004 | 0.521 | 5 Hydroxytryptamine 1A antagonist | 0.367 0.007 CID_153935 0.217 0.013 CID_29984837 0.391 0.006 CID_154699696 | ||
| 0.509 | 0.004 | 0.509 | Alpha 1a adrenoreceptor antagonist | 0.503 0.004 CID_153935 0.293 0.009 CID_29984837 0.437 0.005 CID_154699696 | ||
| 0.507 | 0.003 | 0.507 | 5 Hydroxytryptamine 5A antagonist | 0.381 0.003 CID_153935 0.088 0.02 CID_29984837 0.292 0.004 CID_154699696 | ||
| 0.539 | 0.039 | 0.539 | Analgesic | 0.414 0.078 CID_153935 0.535 0.04 CID_29984837 0.439 0.069 CID_154699696 | ||
| 0.502 | 0.003 | 0.502 | 5 Hydroxytryptamine 1D antagonist | 0.335 0.004 CID_153935 0.086 0.028 CID_29984837 0.294 0.004 CID_154699696 | ||
| 0.5 | 0.011 | 0.5 | Potassium channel blocker | 0.381 0.026 CID_153935 0.272 0.056 CID_154699696 | ||
| 0.509 | 0.022 | 0.561 | Spasmolytic | 0.379 0.045 CID_153935 0.432 0.034 CID_29984837 0.561 0.017 CID_154699696 | CID_154699696 | |
| 0.482 | 0.003 | 0.482 | 5 Hydroxytryptamine 1B antagonist | 0.351 0.004 CID_153935 0.08 0.034 CID_29984837 0.289 0.005 CID_154699696 | ||
| 0.465 | 0.004 | 0.465 | Acetylcholine M1 receptor antagonist | 0.313 0.012 CID_153935 0.462 0.004 CID_29984837 0.441 0.005 CID_154699696 | ||
| 0.458 | 0.003 | 0.458 | 5 Hydroxytryptamine 5 antagonist | 0.331 0.004 CID_153935 0.074 0.024 CID_29984837 0.259 0.004 CID_154699696 | ||
| 0.445 | 0.006 | 0.493 | Cholinergic antagonist | 0.384 0.009 CID_153935 0.493 0.005 CID_29984837 0.421 0.007 CID_154699696 | CID_29984837 | |
| 0.44 | 0.004 | 0.48 | Alpha 1b adrenoreceptor antagonist | 0.371 0.005 CID_153935 0.48 0.004 CID_29984837 0.4 0.005 CID_154699696 | CID_29984837 | |
| 0.439 | 0.006 | 0.468 | Acetylcholine antagonist | 0.38 0.009 CID_153935 0.468 0.005 CID_29984837 0.415 0.007 CID_154699696 | CID_29984837 | |
| 0.426 | 0.003 | 0.509 | Acetylcholine M4 receptor antagonist | 0.227 0.005 CID_153935 0.509 0.003 CID_29984837 0.211 0.005 CID_154699696 | CID_29984837 | |
| 0.419 | 0.004 | 0.419 | Toll-Like receptor antagonist | 0.391 0.004 CID_153935 0.398 0.004 CID_154699696 | ||
| 0.409 | 0.004 | 0.409 | Alpha 1 adrenoreceptor agonist | 0.342 0.004 CID_153935 0.059 0.037 CID_29984837 0.39 0.004 CID_154699696 | ||
| 0.387 | 0.005 | 0.387 | 5 Hydroxytryptamine 1 agonist | 0.246 0.009 CID_153935 0.131 0.016 CID_29984837 0.151 0.014 CID_154699696 | ||
| 0.4 | 0.022 | 0.4 | Sigma receptor agonist | 0.206 0.06 CID_153935 0.171 0.073 CID_29984837 0.4 0.022 CID_154699696 | ||
| 0.382 | 0.005 | 0.382 | Nav1.1 sodium channel blocker | 0.365 0.005 CID_153935 0.193 0.02 CID_29984837 0.337 0.006 CID_154699696 | ||
| 0.355 | 0.003 | 0.85 | 5 Hydroxytryptamine 2C agonist | 0.85 0.002 CID_153935 0.186 0.004 CID_29984837 0.219 0.004 CID_154699696 | CID_153935 | |
| 0.353 | 0.006 | 0.388 | Acetylcholine muscarinic antagonist | 0.247 0.015 CID_153935 0.388 0.005 CID_29984837 0.332 0.007 CID_154699696 | CID_29984837 | |
| 0.348 | 0.003 | 0.686 | 5 Hydroxytryptamine 2 agonist | 0.686 0.002 CID_153935 0.088 0.012 CID_29984837 0.243 0.004 CID_154699696 | CID_153935 | |
| 0.348 | 0.004 | 0.375 | Alpha adrenoreceptor agonist | 0.375 0.004 CID_153935 0.061 0.054 CID_29984837 0.349 0.004 CID_154699696 | CID_153935 | |
| 0.363 | 0.027 | 0.363 | Anticonvulsant | 0.258 0.054 CID_153935 0.171 0.107 CID_154699696 | ||
| 0.396 | 0.063 | 0.442 | GABA C receptor rho-3 antagonist | 0.379 0.071 CID_153935 0.233 0.17 CID_29984837 0.442 0.044 CID_154699696 | CID_154699696 | |
| 0.335 | 0.007 | 0.335 | Nav1.3 sodium channel blocker | 0.203 0.023 CID_153935 0.224 0.018 CID_154699696 | ||
| 0.32 | 0.003 | 0.32 | Acetylcholine M5 receptor antagonist | 0.216 0.004 CID_153935 0.318 0.003 CID_29984837 0.263 0.004 CID_154699696 | ||
| 0.317 | 0.005 | 0.317 | Alpha 1d adrenoreceptor antagonist | 0.249 0.007 CID_153935 0.188 0.01 CID_29984837 0.256 0.007 CID_154699696 | ||
| 0.314 | 0.005 | 0.314 | Dopamine agonist | 0.211 0.009 CID_153935 0.065 0.048 CID_29984837 0.294 0.005 CID_154699696 | ||
| 0.314 | 0.005 | 0.314 | Nav1.6 sodium channel blocker | 0.24 0.011 CID_153935 0.125 0.088 CID_29984837 0.231 0.012 CID_154699696 | ||
| 0.311 | 0.005 | 0.332 | 5 Hydroxytryptamine uptake inhibitor | 0.332 0.005 CID_153935 0.058 0.048 CID_29984837 0.158 0.015 CID_154699696 | CID_153935 | |
| 0.314 | 0.013 | 0.314 | Nav1.2 sodium channel blocker | 0.232 0.025 CID_153935 0.245 0.023 CID_154699696 | ||
| 0.299 | 0.005 | 0.309 | Acetylcholine agonist | 0.287 0.006 CID_153935 0.309 0.005 CID_29984837 0.177 0.019 CID_154699696 | CID_29984837 | |
| 0.304 | 0.012 | 0.304 | Toll-Like receptor 9 antagonist | 0.219 0.028 CID_153935 0.254 0.02 CID_154699696 | ||
| 0.283 | 0.003 | 0.283 | Histamine H4 receptor antagonist | 0.165 0.004 CID_153935 0.057 0.022 CID_29984837 0.103 0.005 CID_154699696 | ||
| 0.292 | 0.024 | 0.292 | Diuretic | 0.18 0.054 CID_153935 0.211 0.04 CID_154699696 | ||
| 0.268 | 0.005 | 0.268 | Dopamine uptake inhibitor | 0.134 0.012 CID_153935 0.177 0.008 CID_154699696 | ||
| 0.296 | 0.035 | 0.339 | Tyrosine 3 hydroxylase inhibitor | 0.303 0.032 CID_153935 0.244 0.074 CID_29984837 0.339 0.019 CID_154699696 | CID_154699696 | |
| 0.35 | 0.092 | 0.372 | MAP kinase kinase 6 inhibitor | 0.372 0.076 CID_153935 0.298 0.137 CID_154699696 | CID_153935 | |
| 0.263 | 0.007 | 0.263 | 5 Hydroxytryptamine 1A agonist | 0.188 0.009 CID_153935 0.126 0.012 CID_29984837 0.089 0.018 CID_154699696 | ||
| 0.275 | 0.023 | 0.42 | Cholinergic | 0.268 0.025 CID_153935 0.42 0.009 CID_29984837 0.211 0.042 CID_154699696 | CID_29984837 | |
| 0.296 | 0.047 | 0.296 | 5 Hydroxytryptamine uptake stimulant | 0.282 0.055 CID_153935 0.274 0.06 CID_154699696 | ||
| 0.291 | 0.045 | 0.3 | Psychostimulant | 0.3 0.043 CID_153935 0.284 0.047 CID_154699696 | CID_153935 | |
| 0.263 | 0.018 | 0.273 | Adenylate cyclase inhibitor | 0.17 0.034 CID_153935 0.273 0.017 CID_154699696 | CID_154699696 | |
| 0.247 | 0.004 | 0.31 | Alpha 2 adrenoreceptor agonist | 0.31 0.003 CID_153935 0.07 0.032 CID_29984837 0.219 0.004 CID_154699696 | CID_153935 | |
| 0.252 | 0.009 | 0.281 | Acetylcholine nicotinic antagonist | 0.281 0.008 CID_153935 0.141 0.023 CID_29984837 0.204 0.012 CID_154699696 | CID_153935 | |
| 0.244 | 0.005 | 0.244 | Dopamine D4 agonist | 0.113 0.012 CID_153935 0.047 0.039 CID_29984837 0.101 0.014 CID_154699696 | ||
| 0.242 | 0.004 | 0.242 | 5 Hydroxytryptamine 6 antagonist | 0.242 0.004 CID_153935 0.06 0.037 CID_29984837 0.138 0.008 CID_154699696 | ||
| 0.319 | 0.088 | 0.343 | Vasodilator, peripheral | 0.343 0.077 CID_153935 0.301 0.096 CID_154699696 | CID_153935 | |
| 0.233 | 0.004 | 0.233 | 5 Hydroxytryptamine 3A antagonist | 0.17 0.004 CID_153935 0.069 0.044 CID_29984837 0.112 0.011 CID_154699696 | ||
| 0.232 | 0.007 | 0.263 | Neuronal nicotinic receptor antagonist | 0.263 0.006 CID_153935 0.121 0.017 CID_29984837 0.182 0.009 CID_154699696 | CID_153935 | |
| 0.268 | 0.046 | 0.295 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.295 0.028 CID_153935 0.194 0.184 CID_29984837 0.213 0.131 CID_154699696 | CID_153935 | |
| 0.224 | 0.005 | 0.263 | Acetylcholine nicotinic agonist | 0.263 0.004 CID_153935 0.074 0.065 CID_29984837 0.168 0.012 CID_154699696 | CID_153935 | |
| 0.29 | 0.072 | 0.294 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.294 0.069 CID_153935 0.277 0.082 CID_154699696 | CID_153935 | |
| 0.27 | 0.057 | 0.27 | Gastrin inhibitor | 0.194 0.158 CID_153935 0.217 0.124 CID_154699696 | ||
| 0.299 | 0.088 | 0.302 | Vasodilator, coronary | 0.249 0.136 CID_153935 0.302 0.086 CID_154699696 | CID_154699696 | |
| 0.354 | 0.146 | 0.387 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.387 0.113 CID_153935 | CID_153935 | |
| 0.21 | 0.005 | 0.26 | Acetylcholine muscarinic agonist | 0.153 0.01 CID_153935 0.26 0.004 CID_29984837 0.068 0.028 CID_154699696 | CID_29984837 | |
| 0.216 | 0.011 | 0.228 | 5 Hydroxytryptamine 3A agonist | 0.228 0.008 CID_153935 0.172 0.025 CID_154699696 | CID_153935 | |
| 0.209 | 0.005 | 0.233 | Adrenaline uptake inhibitor | 0.233 0.005 CID_153935 0.176 0.007 CID_29984837 0.136 0.011 CID_154699696 | CID_153935 | |
| 0.205 | 0.004 | 0.219 | Toll-Like receptor 7 antagonist | 0.219 0.004 CID_153935 0.068 0.048 CID_29984837 0.131 0.009 CID_154699696 | CID_153935 | |
| 0.284 | 0.083 | 0.284 | Nootropic | 0.263 0.097 CID_153935 | ||
| 0.212 | 0.011 | 0.223 | MAP3K9 inhibitor | 0.223 0.009 CID_153935 0.173 0.032 CID_29984837 0.195 0.018 CID_154699696 | CID_153935 | |
| 0.259 | 0.061 | 0.32 | DNA synthesis inhibitor | 0.32 0.037 CID_153935 0.204 0.117 CID_29984837 0.279 0.052 CID_154699696 | CID_153935 | |
| 0.205 | 0.014 | 0.296 | Mediator release inhibitor | 0.122 0.045 CID_153935 0.296 0.007 CID_154699696 | CID_154699696 | |
| 0.194 | 0.007 | 0.238 | Acetylcholine M2 receptor antagonist | 0.114 0.018 CID_153935 0.238 0.005 CID_29984837 0.158 0.01 CID_154699696 | CID_29984837 | |
| 0.221 | 0.036 | 0.221 | Antipruritic | 0.181 0.063 CID_153935 0.212 0.041 CID_154699696 | ||
| 0.219 | 0.037 | 0.229 | 5 Hydroxytryptamine 3E antagonist | 0.229 0.029 CID_153935 0.176 0.118 CID_29984837 0.163 0.161 CID_154699696 | CID_153935 | |
| 0.191 | 0.02 | 0.219 | Chemokine receptor antagonist | 0.219 0.015 CID_153935 0.119 0.048 CID_154699696 | CID_153935 | |
| 0.172 | 0.004 | 0.369 | 5 Hydroxytryptamine 2A agonist | 0.369 0.003 CID_153935 0.064 0.043 CID_29984837 0.158 0.005 CID_154699696 | CID_153935 | |
| 0.173 | 0.007 | 0.173 | Histamine H2 receptor antagonist | 0.122 0.02 CID_153935 0.128 0.017 CID_154699696 | ||
| 0.182 | 0.018 | 0.182 | Protein kinase C gamma inhibitor | 0.175 0.02 CID_153935 0.18 0.019 CID_154699696 | ||
| 0.173 | 0.009 | 0.173 | Acetylcholine M3 receptor agonist | 0.152 0.019 CID_153935 0.079 0.062 CID_29984837 0.141 0.024 CID_154699696 | ||
| 0.169 | 0.005 | 0.191 | Dopamine D2 agonist | 0.105 0.01 CID_153935 0.191 0.005 CID_154699696 | CID_154699696 | |
| 0.176 | 0.015 | 0.214 | Protein kinase C zeta inhibitor | 0.159 0.018 CID_153935 0.214 0.01 CID_154699696 | CID_154699696 | |
| 0.175 | 0.014 | 0.188 | Prolactin inhibitor | 0.151 0.022 CID_153935 0.099 0.056 CID_29984837 0.188 0.011 CID_154699696 | CID_154699696 | |
| 0.169 | 0.009 | 0.199 | Acetylcholine M3 receptor antagonist | 0.13 0.013 CID_153935 0.198 0.007 CID_29984837 0.199 0.007 CID_154699696 | CID_154699696 | |
| 0.161 | 0.005 | 0.161 | Nicotinic receptor alpha7 subunit antagonist | 0.149 0.006 CID_153935 0.115 0.01 CID_154699696 | ||
| 0.155 | 0.007 | 0.194 | Acetylcholine M1 receptor agonist | 0.114 0.011 CID_153935 0.194 0.005 CID_29984837 0.037 0.036 CID_154699696 | CID_29984837 | |
| 0.149 | 0.004 | 0.149 | 5 Hydroxytryptamine 7 agonist | 0.13 0.005 CID_153935 0.059 0.033 CID_29984837 0.126 0.005 CID_154699696 | ||
| 0.231 | 0.088 | 0.361 | Superoxide dismutase inhibitor | 0.361 0.034 CID_153935 0.248 0.076 CID_154699696 | CID_153935 | |
| 0.267 | 0.127 | 0.323 | Calcium channel activator | 0.323 0.07 CID_153935 0.268 0.126 CID_154699696 | CID_153935 | |
| 0.146 | 0.005 | 0.185 | Nicotinic neuronal receptor agonist | 0.185 0.004 CID_153935 0.085 0.018 CID_154699696 | CID_153935 | |
| 0.218 | 0.083 | 0.218 | MAP-kinase-activated kinase 5 inhibitor | 0.202 0.101 CID_153935 0.212 0.09 CID_154699696 | ||
| 0.226 | 0.092 | 0.384 | Aldehyde oxidase inhibitor | 0.384 0.049 CID_154699696 | CID_154699696 | |
| 0.158 | 0.027 | 0.158 | Ca2+-transporting ATPase inhibitor | 0.136 0.088 CID_153935 0.152 0.039 CID_154699696 | ||
| 0.139 | 0.01 | 0.199 | Nicotinic alpha4beta2 receptor antagonist | 0.199 0.004 CID_153935 0.136 0.011 CID_29984837 0.111 0.023 CID_154699696 | CID_153935 | |
| 0.132 | 0.004 | 0.132 | 5 Hydroxytryptamine 4 antagonist | 0.095 0.008 CID_153935 0.1 0.007 CID_154699696 | ||
| 0.146 | 0.019 | 0.146 | Acetylcholine release stimulant | 0.12 0.048 CID_153935 0.109 0.068 CID_154699696 | ||
| 0.13 | 0.007 | 0.13 | 5 Hydroxytryptamine 3 agonist | 0.11 0.011 CID_153935 0.1 0.015 CID_154699696 | ||
| 0.126 | 0.003 | 0.126 | Adenylate cyclase 1 inhibitor | 0.101 0.004 CID_153935 0.056 0.02 CID_29984837 0.117 0.003 CID_154699696 | ||
| 0.131 | 0.009 | 0.131 | Histamine H3 receptor antagonist | 0.064 0.021 CID_153935 | ||
| 0.129 | 0.008 | 0.129 | Acetylcholine M5 receptor agonist | 0.106 0.017 CID_153935 0.082 0.032 CID_154699696 | ||
| 0.134 | 0.015 | 0.134 | Bromodomain-containing protein 2 inhibitor | 0.112 0.029 CID_153935 0.093 0.051 CID_154699696 | ||
| 0.123 | 0.006 | 0.123 | Protein kinase C beta inhibitor | 0.119 0.008 CID_153935 0.114 0.009 CID_154699696 | ||
| 0.12 | 0.009 | 0.12 | Dopamine transporter inhibitor | 0.093 0.013 CID_153935 0.043 0.04 CID_29984837 0.086 0.015 CID_154699696 | ||
| 0.117 | 0.006 | 0.117 | Nicotinic alpha7 receptor agonist | 0.099 0.01 CID_153935 0.056 0.035 CID_154699696 | ||
| 0.205 | 0.1 | 0.23 | Vasodilator | 0.184 0.118 CID_153935 0.23 0.082 CID_154699696 | CID_154699696 | |
| 0.107 | 0.004 | 0.107 | Acetylcholine M4 receptor agonist | 0.07 0.007 CID_153935 0.034 0.019 CID_154699696 | ||
| 0.107 | 0.007 | 0.127 | Toll-Like receptor 8 antagonist | 0.127 0.005 CID_153935 | CID_153935 | |
| 0.112 | 0.014 | 0.112 | Protein kinase C eta inhibitor | 0.088 0.021 CID_153935 0.108 0.015 CID_154699696 | ||
| 0.221 | 0.128 | 0.277 | Hypoxia-inducible factor 1 alpha inhibitor | 0.213 0.137 CID_153935 0.277 0.078 CID_154699696 | CID_154699696 | |
| 0.096 | 0.005 | 0.096 | Prolactin release inhibitor | 0.089 0.007 CID_153935 0.084 0.009 CID_29984837 0.088 0.007 CID_154699696 | ||
| 0.098 | 0.007 | 0.098 | 5 Hydroxytryptamine 1B agonist | 0.081 0.012 CID_153935 0.065 0.022 CID_154699696 | ||
| 0.098 | 0.007 | 0.098 | Acetylcholine M2 receptor agonist | 0.086 0.01 CID_153935 0.057 0.033 CID_29984837 0.076 0.016 CID_154699696 | ||
| 0.097 | 0.007 | 0.097 | Potassium channel small-conductance Ca-activated blocker | 0.081 0.01 CID_153935 0.041 0.039 CID_154699696 | ||
| 0.099 | 0.01 | 0.109 | Cyclin-dependent kinase 6 inhibitor | 0.109 0.008 CID_153935 0.07 0.031 CID_154699696 | CID_153935 | |
| 0.11 | 0.025 | 0.14 | Glycine receptor antagonist | 0.14 0.01 CID_153935 0.072 0.071 CID_29984837 0.085 0.049 CID_154699696 | CID_153935 | |
| 0.114 | 0.031 | 0.115 | Phosphodiesterase 6D inhibitor | 0.115 0.03 CID_154699696 | CID_154699696 | |
| 0.108 | 0.029 | 0.145 | Opioid kappa receptor antagonist | 0.09 0.046 CID_153935 0.145 0.017 CID_154699696 | CID_154699696 | |
| 0.091 | 0.012 | 0.091 | Potassium channel (Ca-activated) blocker | 0.083 0.016 CID_153935 0.064 0.035 CID_154699696 | ||
| 0.143 | 0.066 | 0.143 | Pregnane X receptor agonist | 0.126 0.112 CID_153935 0.123 0.12 CID_154699696 | ||
| 0.198 | 0.123 | 0.214 | Interleukin agonist | 0.214 0.108 CID_153935 | CID_153935 | |
| 0.08 | 0.005 | 0.08 | 5 Hydroxytryptamine 1D agonist | 0.036 0.016 CID_153935 | ||
| 0.116 | 0.041 | 0.175 | Nitric-oxide synthase inhibitor | 0.175 0.015 CID_153935 | CID_153935 | |
| 0.085 | 0.012 | 0.085 | CC chemokine 5 receptor antagonist | 0.078 0.014 CID_153935 0.055 0.031 CID_154699696 | ||
| 0.076 | 0.005 | 0.301 | 5 Hydroxytryptamine 2B agonist | 0.301 0.002 CID_153935 0.041 0.022 CID_29984837 0.048 0.015 CID_154699696 | CID_153935 | |
| 0.075 | 0.003 | 0.09 | Nicotinic alpha3beta4 receptor agonist | 0.09 0.003 CID_153935 0.034 0.015 CID_29984837 0.058 0.004 CID_154699696 | CID_153935 | |
| 0.107 | 0.037 | 0.108 | ALK inhibitor | 0.108 0.036 CID_153935 0.084 0.054 CID_154699696 | CID_153935 | |
| 0.114 | 0.045 | 0.174 | Protein kinase C mu inhibitor | 0.174 0.017 CID_153935 0.096 0.061 CID_154699696 | CID_153935 | |
| 0.142 | 0.073 | 0.142 | Activin receptor-like kinase 2 inhibitor | 0.129 0.086 CID_153935 | ||
| 0.107 | 0.04 | 0.128 | Histamine N-methyltransferase inhibitor | 0.128 0.024 CID_153935 0.079 0.067 CID_154699696 | CID_153935 | |
| 0.144 | 0.082 | 0.156 | GABA C receptor rho-2 antagonist | 0.156 0.066 CID_153935 0.143 0.083 CID_154699696 | CID_153935 | |
| 0.077 | 0.015 | 0.077 | Histamine agonist | 0.061 0.027 CID_153935 | ||
| 0.117 | 0.056 | 0.117 | Falcipain 3 inhibitor | |||
| 0.073 | 0.012 | 0.139 | Kinesin antagonist | 0.098 0.008 CID_153935 0.139 0.005 CID_29984837 0.061 0.014 CID_154699696 | CID_29984837 | |
| 0.073 | 0.012 | 0.139 | Kinesin-like protein 1 inhibitor | 0.098 0.008 CID_153935 0.139 0.005 CID_29984837 0.061 0.014 CID_154699696 | CID_29984837 | |
| 0.113 | 0.054 | 0.14 | Platelet activating factor beta antagonist | 0.14 0.042 CID_29984837 0.106 0.059 CID_154699696 | CID_29984837 | |
| 0.079 | 0.021 | 0.079 | Sigma receptor antagonist | 0.041 0.04 CID_153935 0.057 0.03 CID_154699696 | ||
| 0.109 | 0.051 | 0.109 | Insulin receptor antagonist | 0.088 0.08 CID_153935 | ||
| 0.064 | 0.008 | 0.064 | Nerve growth factor antagonist | 0.049 0.02 CID_154699696 | ||
| 0.092 | 0.039 | 0.092 | Phosphodiesterase 11A inhibitor | |||
| 0.092 | 0.039 | 0.092 | Phosphodiesterase XI inhibitor | |||
| 0.07 | 0.017 | 0.125 | Nicotinic receptor alpha4 subunit antagonist | 0.125 0.005 CID_153935 0.054 0.027 CID_154699696 | CID_153935 | |
| 0.1 | 0.048 | 0.14 | Opioid antagonist | 0.086 0.061 CID_153935 0.14 0.029 CID_154699696 | CID_154699696 | |
| 0.064 | 0.013 | 0.064 | Dopamine D3 agonist | 0.049 0.02 CID_153935 0.058 0.015 CID_154699696 | ||
| 0.107 | 0.056 | 0.31 | Bronchodilator | 0.083 0.082 CID_153935 0.31 0.009 CID_29984837 0.126 0.041 CID_154699696 | CID_29984837 | |
| 0.274 | 0.224 | 0.358 | Caspase 9 stimulant | 0.28 0.217 CID_153935 0.358 0.139 CID_154699696 | CID_154699696 | |
| 0.104 | 0.055 | 0.202 | Creatine kinase inhibitor | 0.202 0.01 CID_154699696 | CID_154699696 | |
| 0.053 | 0.004 | 0.061 | 5 Hydroxytryptamine 6 agonist | 0.061 0.004 CID_153935 0.03 0.017 CID_154699696 | CID_153935 | |
| 0.13 | 0.083 | 0.184 | Protein kinase stimulant | 0.184 0.048 CID_154699696 | CID_154699696 | |
| 0.09 | 0.042 | 0.097 | CC chemokine receptor antagonist | 0.097 0.037 CID_153935 | CID_153935 | |
| 0.113 | 0.068 | 0.113 | Platelet activating factor antagonist | 0.097 0.081 CID_29984837 0.108 0.072 CID_154699696 | ||
| 0.169 | 0.124 | 0.169 | Cyclic AMP phosphodiesterase inhibitor | 0.167 0.126 CID_153935 0.16 0.135 CID_154699696 | ||
| 0.109 | 0.064 | 0.109 | Multidrug resistance-associated protein 1 inhibitor | 0.102 0.075 CID_154699696 | ||
| 0.048 | 0.005 | 0.064 | Nicotinic alpha4beta2 receptor agonist | 0.064 0.004 CID_153935 0.036 0.01 CID_154699696 | CID_153935 | |
| 0.061 | 0.019 | 0.076 | Nicotinic receptor alpha3 subunit antagonist | 0.076 0.014 CID_153935 0.045 0.029 CID_154699696 | CID_153935 | |
| 0.074 | 0.034 | 0.157 | CXC chemokine 4 receptor antagonist | 0.157 0.014 CID_153935 0.057 0.044 CID_154699696 | CID_153935 | |
| 0.074 | 0.035 | 0.074 | Glutamate (mGluR7) antagonist | 0.067 0.048 CID_154699696 | ||
| 0.081 | 0.042 | 0.081 | MAP kinase 7 inhibitor | 0.078 0.052 CID_154699696 | ||
| 0.066 | 0.029 | 0.066 | Phosphodiesterase 1A inhibitor | |||
| 0.12 | 0.084 | 0.12 | Sodium channel blocker | 0.116 0.089 CID_153935 | ||
| 0.042 | 0.007 | 0.042 | Protein kinase C beta I inhibitor | 0.038 0.011 CID_153935 0.04 0.009 CID_154699696 | ||
| 0.098 | 0.064 | 0.146 | GABA C receptor rho-1 antagonist | 0.146 0.023 CID_153935 0.091 0.077 CID_154699696 | CID_153935 | |
| 0.084 | 0.05 | 0.089 | CC chemokine 5 receptor agonist | 0.089 0.039 CID_153935 0.086 0.047 CID_154699696 | CID_153935 | |
| 0.105 | 0.072 | 0.105 | Polo-like kinase-4 inhibitor | |||
| 0.05 | 0.019 | 0.052 | Histamine H1 receptor agonist | 0.052 0.016 CID_153935 | CID_153935 | |
| 0.034 | 0.004 | 0.106 | Nicotinic alpha4 receptor agonist | 0.106 0.003 CID_153935 0.018 0.009 CID_154699696 | CID_153935 | |
| 0.04 | 0.012 | 0.04 | Adenosine uptake inhibitor | |||
| 0.09 | 0.062 | 0.118 | Polo-like kinase-1 inhibitor | 0.118 0.031 CID_29984837 | CID_29984837 | |
| 0.072 | 0.044 | 0.114 | Opioid mu receptor antagonist | 0.114 0.027 CID_154699696 | CID_154699696 | |
| 0.116 | 0.089 | 0.135 | Sodium channel (voltage-gated) blocker | 0.135 0.067 CID_153935 0.106 0.102 CID_29984837 | CID_153935 | |
| 0.045 | 0.018 | 0.045 | Nociceptin (N/OFQ) receptor antagonist | 0.045 0.017 CID_153935 | ||
| 0.042 | 0.015 | 0.042 | ATM kinase inhibitor | 0.034 0.032 CID_153935 | ||
| 0.074 | 0.047 | 0.085 | Glycine receptor agonist | 0.085 0.033 CID_153935 | CID_153935 | |
| 0.039 | 0.013 | 0.039 | Sigma 2 receptor antagonist | 0.027 0.018 CID_154699696 | ||
| 0.056 | 0.03 | 0.066 | Dipeptidyl peptidase inhibitor | 0.066 0.02 CID_153935 | CID_153935 | |
| 0.063 | 0.038 | 0.069 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.069 0.029 CID_154699696 | CID_154699696 | |
| 0.049 | 0.025 | 0.049 | Phosphodiesterase 6C inhibitor | 0.044 0.04 CID_154699696 | ||
| 0.034 | 0.01 | 0.034 | 5 Hydroxytryptamine 1F agonist | |||
| 0.096 | 0.073 | 0.181 | Estrogen receptor beta antagonist | 0.102 0.06 CID_153935 0.181 0.011 CID_154699696 | CID_154699696 | |
| 0.033 | 0.011 | 0.041 | Estrogen-related receptor gamma antagonist | 0.041 0.005 CID_154699696 | CID_154699696 | |
| 0.061 | 0.039 | 0.068 | Androgen agonist | 0.054 0.05 CID_153935 0.068 0.032 CID_154699696 | CID_154699696 | |
| 0.132 | 0.111 | 0.134 | Heat shock protein 70 antagonist | 0.134 0.101 CID_154699696 | CID_154699696 | |
| 0.045 | 0.025 | 0.045 | Antidiuretic hormone antagonist | |||
| 0.076 | 0.056 | 0.135 | Estrogen receptor alpha antagonist | 0.085 0.042 CID_153935 0.135 0.014 CID_154699696 | CID_154699696 | |
| 0.179 | 0.161 | 0.185 | Neuropeptide Y2 antagonist | 0.185 0.149 CID_153935 | CID_153935 | |
| 0.073 | 0.056 | 0.073 | Vanilloid 4 agonist | |||
| 0.095 | 0.078 | 0.101 | Granulocyte macrophage colony stimulating factor antagonist | 0.101 0.07 CID_29984837 | CID_29984837 | |
| 0.087 | 0.07 | 0.087 | Glutamate release inhibitor | |||
| 0.05 | 0.033 | 0.05 | Bromodomain-containing protein 3 inhibitor | |||
| 0.053 | 0.037 | 0.053 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.035 | 0.018 | 0.04 | Protein kinase C beta II inhibitor | 0.04 0.011 CID_153935 0.033 0.021 CID_154699696 | CID_153935 | |
| 0.042 | 0.026 | 0.088 | Dopamine D5 agonist | 0.088 0.005 CID_153935 0.072 0.008 CID_154699696 | CID_153935 | |
| 0.036 | 0.02 | 0.036 | Vasopressin 2 antagonist | |||
| 0.143 | 0.128 | 0.191 | Antimitotic | 0.191 0.089 CID_154699696 | CID_154699696 | |
| 0.071 | 0.059 | 0.092 | Analgesic, opioid | 0.092 0.036 CID_154699696 | CID_154699696 | |
| 0.066 | 0.055 | 0.097 | CXC chemokine receptor antagonist | 0.097 0.026 CID_153935 | CID_153935 | |
| 0.099 | 0.087 | 0.099 | Nav1.5 sodium channel blocker | |||
| 0.058 | 0.048 | 0.059 | Cannabinoid CB1 receptor antagonist | 0.059 0.046 CID_153935 | CID_153935 | |
| 0.03 | 0.019 | 0.03 | Vasopressin 1A antagonist | |||
| 0.044 | 0.034 | 0.044 | Farnesyltransferase inhibitor | |||
| 0.074 | 0.065 | 0.089 | MAP kinase kinase 7 inhibitor | 0.089 0.027 CID_153935 0.088 0.028 CID_154699696 | CID_153935 | |
| 0.059 | 0.05 | 0.059 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.051 | 0.042 | 0.06 | Nicotinic alpha3beta2 receptor antagonist | 0.052 0.04 CID_153935 0.06 0.027 CID_29984837 | CID_29984837 | |
| 0.03 | 0.022 | 0.03 | Potassium channel (Inward rectifier) 1 blocker | |||
| 0.082 | 0.074 | 0.148 | Protein kinase C delta inhibitor | 0.118 0.038 CID_153935 0.148 0.022 CID_29984837 | CID_29984837 | |
| 0.031 | 0.024 | 0.031 | Vasopressin 1 antagonist | |||
| 0.035 | 0.028 | 0.04 | 5-Alpha-reductase inhibitor | 0.04 0.024 CID_154699696 | CID_154699696 | |
| 0.065 | 0.059 | 0.065 | Polo-like kinase-2 inhibitor | |||
| 0.042 | 0.036 | 0.05 | Dipeptidyl peptidase IV inhibitor | 0.05 0.021 CID_153935 | CID_153935 | |
| 0.018 | 0.013 | 0.018 | Histamine H4 receptor agonist | |||
| 0.029 | 0.024 | 0.029 | Phosphodiesterase 6B inhibitor | |||
| 0.143 | 0.138 | 0.169 | Platelet aggregation inhibitor | 0.142 0.139 CID_153935 0.142 0.139 CID_29984837 0.169 0.107 CID_154699696 | CID_154699696 | |
| 0.16 | 0.155 | 0.216 | ErbB-1 antagonist | 0.216 0.073 CID_154699696 | CID_154699696 | |
| 0.022 | 0.019 | 0.022 | Phosphodiesterase 6G inhibitor | |||
| 0.022 | 0.019 | 0.022 | Phosphodiesterase 6H inhibitor | |||
| 0.018 | 0.015 | 0.019 | 5-Alpha-reductase 2 inhibitor | 0.018 0.016 CID_153935 0.019 0.013 CID_154699696 | CID_154699696 | |
| 0.014 | 0.012 | 0.014 | NMDA receptor phencyclidine site antagonist | 0.014 0.013 CID_153935 0.014 0.012 CID_154699696 | ||
| 0.036 | 0.035 | 0.036 | Neurokinin 1 antagonist | |||
| 0.018 | 0.018 | 0.024 | Nociceptin (N/OFQ) receptor agonist | 0.024 0.012 CID_153935 | CID_153935 | |
| 0.012 | 0.012 | 0.014 | Cyclin D2 inhibitor | 0.014 0.007 CID_153935 | CID_153935 | |
| 0.1 | 0.1 | 0.185 | Estrogen antagonist | 0.107 0.081 CID_153935 0.185 0.015 CID_154699696 | CID_154699696 | |
| 0.06 | 0.061 | 0.081 | Protein kinase C alpha inhibitor | 0.081 0.033 CID_153935 | CID_153935 | |
| 0.02 | 0.021 | 0.026 | Dopamine D1 agonist | 0.026 0.012 CID_154699696 | CID_154699696 | |
| 0.01 | 0.013 | 0.013 | Melatonin 2 antagonist | 0.013 0.007 CID_153935 | CID_153935 | |
| 0.099 | 0.103 | 0.133 | Alpha-N-acetylglucosaminidase inhibitor | 0.133 0.066 CID_153935 | CID_153935 | |
| 0.057 | 0.061 | 0.066 | Bcl2 antagonist | 0.066 0.047 CID_154699696 | CID_154699696 | |
| 0.036 | 0.041 | 0.044 | Opioid kappa receptor agonist | 0.044 0.029 CID_154699696 | CID_154699696 | |
| 0.068 | 0.075 | 0.125 | Adrenaline agonist | 0.107 0.032 CID_153935 0.125 0.023 CID_154699696 | CID_154699696 | |
| 0.039 | 0.046 | 0.097 | Poly(ADP-ribose) polymerase inhibitor | 0.097 0.008 CID_153935 0.08 0.01 CID_29984837 | CID_153935 | |
| 0.032 | 0.04 | 0.044 | Vascular adhesion protein 1 inhibitor | 0.044 0.021 CID_153935 | CID_153935 | |
| 0.053 | 0.061 | 0.056 | DNA gyrase inhibitor | 0.056 0.054 CID_153935 | CID_153935 | |
| 0.098 | 0.107 | 0.153 | Cyclooxygenase 3 inhibitor | 0.153 0.046 CID_153935 0.114 0.084 CID_154699696 | CID_153935 | |
| 0.042 | 0.051 | 0.066 | Topoisomerase II beta inhibitor | 0.066 0.018 CID_153935 0.045 0.043 CID_154699696 | CID_153935 | |
| 0.058 | 0.068 | 0.063 | Calcium channel P-type blocker | 0.063 0.048 CID_153935 | CID_153935 | |
| 0.139 | 0.149 | 0.155 | Focal adhesion kinase 2 inhibitor | 0.155 0.123 CID_153935 | CID_153935 | |
| 0.023 | 0.035 | 0.041 | Endothelial nitric-oxide synthase inhibitor | 0.041 0.013 CID_153935 | CID_153935 | |
| 0.077 | 0.089 | 0.092 | Thioredoxin inhibitor | 0.092 0.059 CID_154699696 | CID_154699696 | |
| 0.084 | 0.1 | 0.174 | GABA receptor agonist | 0.174 0.025 CID_29984837 | CID_29984837 | |
| 0.026 | 0.043 | 0.043 | Estrogen-related receptor beta antagonist | 0.043 0.009 CID_154699696 | CID_154699696 | |
| 0.084 | 0.102 | 0.099 | Glutamate (mGluR7) agonist | 0.099 0.062 CID_153935 | CID_153935 | |
| 0.043 | 0.062 | 0.091 | Opioid delta receptor antagonist | 0.091 0.032 CID_154699696 | CID_154699696 | |
| 0.085 | 0.105 | 0.14 | GABA C receptor antagonist | 0.14 0.036 CID_153935 | CID_153935 | |
| 0.067 | 0.086 | 0.134 | NMDA receptor antagonist | 0.134 0.03 CID_153935 0.108 0.042 CID_154699696 | CID_153935 | |
| 0.052 | 0.072 | 0.152 | NMDA 2 receptor antagonist | 0.152 0.016 CID_153935 0.102 0.031 CID_154699696 | CID_153935 | |
| 0.084 | 0.104 | 0.106 | Toll-Like receptor 4 antagonist | 0.106 0.061 CID_154699696 | CID_154699696 | |
| 0.151 | 0.172 | 0.177 | DNA damaging | 0.177 0.137 CID_154699696 | CID_154699696 | |
| 0.032 | 0.054 | 0.062 | Phenylethanolamine N methyltransferase inhibitor | 0.062 0.007 CID_153935 | CID_153935 | |
| 0.026 | 0.052 | 0.079 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.079 0.009 CID_153935 0.075 0.01 CID_29984837 | CID_153935 | |
| 0.013 | 0.04 | 0.028 | Imidazoline I1 receptor antagonist | 0.028 0.008 CID_153935 | CID_153935 | |
| 0.064 | 0.092 | 0.143 | MAP-kinase-activated kinase inhibitor | 0.143 0.017 CID_153935 | CID_153935 | |
| 0.113 | 0.142 | 0.124 | Neuropeptide Y1 antagonist | 0.124 0.114 CID_153935 | CID_153935 | |
| 0.052 | 0.084 | 0.065 | Beta 3 adrenoreceptor antagonist | 0.065 0.042 CID_153935 0.063 0.046 CID_154699696 | CID_153935 | |
| 0.056 | 0.09 | 0.104 | Phospholipase D inhibitor | 0.104 0.012 CID_153935 | CID_153935 | |
| 0.093 | 0.127 | 0.123 | NADPH oxidase inhibitor | 0.123 0.079 CID_154699696 | CID_154699696 | |
| 0.063 | 0.1 | 0.113 | Inducible nitric-oxide synthase inhibitor | 0.113 0.028 CID_153935 | CID_153935 | |
| 0.088 | 0.125 | 0.154 | Acetylcholinesterase inhibitor | 0.154 0.053 CID_29984837 | CID_29984837 | |
| 0.03 | 0.068 | 0.05 | Opioid agonist | 0.05 0.04 CID_154699696 | CID_154699696 | |
| 0.072 | 0.11 | 0.157 | GABA C receptor agonist | 0.157 0.031 CID_153935 | CID_153935 | |
| 0.03 | 0.068 | 0.045 | Opioid mu receptor agonist | 0.045 0.034 CID_154699696 | CID_154699696 | |
| 0.126 | 0.165 | 0.178 | Phospholipase C inhibitor | 0.178 0.063 CID_153935 0.139 0.131 CID_154699696 | CID_153935 | |
| 0.07 | 0.114 | 0.087 | Phosphodiesterase 7B inhibitor | 0.087 0.075 CID_153935 | CID_153935 | |
| 0.056 | 0.105 | 0.064 | MDM2 inhibitor | 0.064 0.059 CID_153935 | CID_153935 | |
| 0.037 | 0.086 | 0.066 | NMDA 2C receptor antagonist | 0.066 0.037 CID_153935 | CID_153935 | |
| 0.04 | 0.09 | 0.072 | Cyclin-dependent kinase 4 inhibitor | 0.072 0.04 CID_153935 | CID_153935 | |
| 0.021 | 0.073 | 0.038 | Alpha 1d adrenoreceptor agonist | 0.038 0.029 CID_153935 | CID_153935 | |
| 0.107 | 0.159 | 0.128 | Adenylate cyclase stimulant | 0.128 0.106 CID_153935 | CID_153935 | |
| 0.025 | 0.077 | 0.04 | NMDA receptor subunit 3B antagonist | 0.04 0.034 CID_154699696 | CID_154699696 | |
| 0.22 | 0.273 | 0.281 | 5 Hydroxytryptamine release inhibitor | 0.281 0.187 CID_153935 | CID_153935 | |
| 0.101 | 0.16 | 0.137 | NOS3 expression enhancer | 0.137 0.088 CID_154699696 | CID_154699696 | |
| 0.073 | 0.135 | 0.096 | Alkylator | 0.096 0.093 CID_154699696 | CID_154699696 | |
| 0.045 | 0.108 | 0.09 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.09 0.043 CID_154699696 | CID_154699696 | |
| 0.046 | 0.115 | 0.126 | MAP-kinase-activated kinase 2 inhibitor | 0.126 0.018 CID_153935 | CID_153935 | |
| 0.02 | 0.092 | 0.07 | NMDA 2A receptor antagonist | 0.07 0.024 CID_153935 | CID_153935 | |
| 0.06 | 0.135 | 0.158 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.158 0.044 CID_29984837 | CID_29984837 | |
| 0.02 | 0.096 | 0.042 | Substance P antagonist | 0.042 0.024 CID_29984837 | CID_29984837 | |
| 0.059 | 0.135 | 0.158 | Abl kinase inhibitor | 0.158 0.044 CID_29984837 | CID_29984837 | |
| 0.062 | 0.139 | 0.122 | Topoisomerase II inhibitor | 0.122 0.065 CID_154699696 | CID_154699696 | |
| 0.054 | 0.131 | 0.08 | Antineoplastic alkaloid | 0.08 0.065 CID_154699696 | CID_154699696 | |
| 0.035 | 0.113 | 0.076 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.076 0.045 CID_29984837 | CID_29984837 | |
| 0.062 | 0.141 | 0.097 | DNA intercalator | 0.097 0.077 CID_29984837 | CID_29984837 | |
| 0.065 | 0.144 | 0.084 | Estrogen-related receptor beta agonist | 0.084 0.055 CID_154699696 | CID_154699696 | |
| 0.037 | 0.117 | 0.083 | Check point kinase 1 inhibitor | 0.083 0.037 CID_153935 | CID_153935 | |
| 0.116 | 0.199 | 0.148 | Neurotrophic factor enhancer | 0.148 0.141 CID_154699696 | CID_154699696 | |
| 0.032 | 0.115 | 0.042 | Parathyroid hormone antagonist | 0.042 0.04 CID_153935 | CID_153935 | |
| 0.048 | 0.149 | 0.103 | Topoisomerase I inhibitor | 0.103 0.068 CID_154699696 | CID_154699696 | |
| 0.028 | 0.136 | 0.048 | NMDA 2B receptor antagonist | 0.048 0.047 CID_154699696 | CID_154699696 | |
| 0.055 | 0.169 | 0.099 | Cystathionine beta-synthase inhibitor | 0.099 0.078 CID_154699696 | CID_154699696 | |
| 0.064 | 0.189 | 0.097 | Activin receptor-like kinase 4 inhibitor | 0.097 0.093 CID_153935 | CID_153935 | |
| 0.044 | 0.172 | 0.081 | Pim-3 kinase inhibitor | 0.081 0.075 CID_153935 | CID_153935 | |
| 0.029 | 0.166 | 0.079 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.079 0.051 CID_153935 | CID_153935 | |
| 0.059 | 0.201 | 0.153 | Lipid peroxidase inhibitor | 0.153 0.066 CID_154699696 | CID_154699696 | |
| 0.022 | 0.185 | 0.049 | Purinergic P2X4 antagonist | 0.049 0.026 CID_153935 | CID_153935 | |
| 0.073 | 0.237 | 0.12 | Heat shock protein 90 antagonist | 0.12 0.114 CID_154699696 | CID_154699696 | |
| 0.004 | 0.17 | 0.031 | Estrogen receptor beta agonist | 0.031 0.023 CID_154699696 | CID_154699696 | |
| 0.056 | 0.234 | 0.099 | Alpha 2d adrenoreceptor antagonist | 0.099 0.049 CID_153935 | CID_153935 | |
| 0.025 | 0.204 | 0.059 | Protein kinase C iota inhibitor | 0.059 0.041 CID_153935 | CID_153935 | |
| 0.134 | 0.315 | 0.198 | Apoptosis antagonist | 0.198 0.181 CID_154699696 | CID_154699696 | |
| 0.008 | 0.205 | 0.053 | Estrogen agonist | 0.053 0.034 CID_154699696 | CID_154699696 | |
| 0.065 | 0.314 | 0.347 | Polo-like kinase-3 inhibitor | 0.347 0.005 CID_29984837 | CID_29984837 | |
| 0.009 | 0.261 | 0.147 | Raf kinase B inhibitor | 0.147 0.014 CID_29984837 | CID_29984837 | |
| 0.011 | 0.294 | 0.13 | Raf kinase inhibitor | 0.13 0.023 CID_29984837 | CID_29984837 | |
| 0.124 | 0.413 | 0.251 | Apoptosis agonist | 0.251 0.213 CID_154699696 | CID_154699696 | |
| 0.014 | 0.332 | 0.132 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.132 0.034 CID_29984837 | CID_29984837 | |
| 0.017 | 0.421 | 0.051 | Alpha 1L adrenoreceptor agonist | 0.051 0.015 CID_153935 | CID_153935 | |
| 0.018 | 0.51 | 0.113 | Ephrin antagonist | 0.113 0.054 CID_29984837 | CID_29984837 | |
| 0.048 | 0.577 | 0.592 | Toll-Like receptor 7 agonist | 0.592 0.018 CID_29984837 | CID_29984837 | |
| 0.045 | 0.586 | 0.584 | Toll-Like receptor agonist | 0.584 0.019 CID_29984837 | CID_29984837 | |
| 0.092 | 0.665 | 0.288 | Calcium channel L-type activator | 0.288 0.168 CID_154699696 | CID_154699696 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |